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a Saudi ArabiaBackground and aim: Chylothorax is the accumulation of chyle in the pleural cavity, which usually develops after
disruption of the thoracic duct along its intra-thoracic route. In the majority of cases, this rupture is secondary to trauma
(including cardio thoracic surgeries). Chylothorax is a potentially serious complication after cardiovascular surgeries
that require early diagnosis and adequate management. This study aims to determine the risk factors and the impact of
chylothorax on the early postoperative course after pediatric cardiac surgery.
Methods: A retrospective study of all cases complicated with chylothorax after pediatric cardiac surgery was con-
ducted at King Abdulaziz Cardiac Center between January 2007 and December 2009.
Results: There were 1135 cases operated on during the study period. Of these, 57 cases (5%) were complicated by
chylothorax in the postoperative period. Thirty patients (54%) were males, while 27 (47%) were females. Ages ranged
from 4 to 2759 days. The most common surgeries complicated by chylothorax were the single ventricle repair surger-
ies (15 cases, 27%); arch repairs (10 cases, 18%); ventricular septal defect repairs (10 cases, 18%); atrioventricular sep-
tal defect repairs (7 cases, 12%); arterial switch repair (6 cases, 11%), and others (8 cases, 14%). The intensive care unit
(ICU) and the length of hospital stays were significantly longer in the chylothorax group. Additionally, some early
postoperative parameters such as incidence of sepsis, ventilation time, and inotropes duration and number were
higher in the chylothorax group.
Conclusion: Chylothorax after pediatric cardiac surgery is not a rare complication. It occurs more commonly with
single ventricle repair and aortic arch repair surgeries, and has a significant impact on the postoperative course and
post operative morbidity.
 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Abbreviations
ICU intensive care unit
TPN total parenteral nutrition
RACHS-1 risk adjustment in cardiac surgery
NPO nil per oral
MCT medium chain triglycerides
SVC superior vena cava
VSD ventricular septal defect
AVSD atrio ventricular septal defect
kg kilogram
cm centimeter
LOHS length of hospital stay
H hours
min minutes
no number
CPR cardio-pulmonary resuscitation
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Chyle is a milky colored fluid enriched withemulsified fat (chylomicrons) absorbed by
intestinal cells, transported by lymphatic channels
that converge to become the thoracic duct, and
passed into the circulation. The diagnosis of chylo-
thorax depends on analysis of the pleural fluid,
with identification of chylomicrons or high triglyc-
eride concentrations [1,2]. Chylothorax is the pres-
ence of lymphatic fluid in the pleural space and is
usually the result of a leak from the thoracic duct
or one of its tributaries along its intra-thoracic
route. The presence of chylothorax can be due to
congenital, traumatic, neoplastic thrombosis of
one of the major neck veins or miscellaneous
causes. Traumatic chylothorax may result from
blunt or penetrating trauma, or occur after various
surgical procedures. Operative injuries are by far
the most common cause of traumatic chylothorax.
Chylothorax complicates different types of car-
diac, aortic, esophageal, pulmonary, neck, sympa-
thetic nerve, and diaphragmatic operations [2].
There are usually 0–10 days between injury of
the thoracic duct and development of chylothorax.
Chylothorax is a potentially life-threatening
disorder that can lead to serious metabolic, immu-
nologic and nutritional complications. Initial
management is the same regardless of the cause
of chylothorax. Low fat diet, total parenteral
nutrition (TPN), octreotide, and surgical proce-
dures have been described for management [2]
(See Fig. 1).Figure 1. Principles of treatment of chylothorax in children.Aim of the study
The present study aims to determine the inci-
dence, risk factors, and the impact of chylothorax
on the early postoperative outcome after pediatric
cardiovascular surgery.Material and methods
Patients
We conducted a retrospective study of all cases
complicated with chylothorax after pediatric car-
diac surgery at King Abdulaziz Cardiac Center be-
tween January 2007 and December 2009. This
group of patients was compared to a control group
of pediatric post open heart surgery patients hav-
ing similar demographic data and the same risk
category (Table 1). The design of the study was
based on a case-matching design by selecting a
group of patients who matched the study patients
in the chylothorax group. The control group was
randomly selected from our departmental data-
base after excluding the patients complicated with
chylothorax. They were selected for the same
diagnosis, surgical procedures and risk category
as the group with chylothorax. We used the risk
adjustment in cardiac surgery (RACHS-1) method
as described by Jenkins to define the surgical risk
category for patients with chylothorax and the
control group [3,4]. The chylothorax group and
the control group were compared regarding early
postoperative course, mortality, and post opera-
tive complications. We used departmental data-
base to collect data, including medical records,
progress notes, and patients’ daily chart reviews.
Diagnosis
Chylothorax was suspected when there was
excessive filling of the pleural cavity after pediat-
Table 1. Demographic data.
Variable Chylothorax (57) Control (53) P value
Age (days) 314 ± 468 238 ± 400 0.36
Male/female 30/27 30/23
Weight (kg) 6.2 ± 3 5.8 ± 3 0.48
Height (cm) 65 ± 14 66 ± 15 0.71
Risk category (RACHS) 2.3 ± 0.75 2.3 ± 0 1
kg: Kilogram, cm: Centimeter, RACHS: risk adjustment in congenital heart disease score.
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OPERATIVE OUTCOME AFTER PEDIATRIC
CARDIOVASCULAR SURGERYric open heart surgery, or excessive drainage from
surgically inserted chest tubes. The chylous fluid
is typically milky and non-clotting; however, it
may not be milky in the fasting state. The triglyc-
eride concentration of the fluid should be mea-
sured. Concentrations above 1.1 mmol/L in the
pleural fluid or a high ratio between the pleural
fluid triglyceride and serum triglyceride (more
than 1) are diagnostic of postoperative chylothorax
[5]. Chylothorax fluid also has lymphocyte levels
that are higher than the corresponding plasma
values, often greater than 90% of the total white
cell count [5]. We used lymphoscintigraphy for
chyle leak localization in patients requiring tho-
racic duct ligation, during which 99mTc human
albumin was injected into the dorsum of the foot
or hand followed by thoracic-duct imaging. In
consideration of the patient’s pain and radiation
exposure, a decision was made for chyle leak
localization in chylothorax not to be included in
the diagnostic approach unless thoracic-duct liga-
tion is necessary.
Management
We do not follow a special protocol for the man-
agement of chylothorax cases. Management is
according to the attending physician’s discretion.
Patients with high drainage early after surgery
are treated mainly by keeping them at nil per
mouth (NPO) and TPN until chyle drainage de-
creases. Octreotide intravenous infusion is added
in cases not responding to TPN alone. When
drainage decreases, patients are started on med-
ium chain triglycerides (MCT oil) based formulas
for another one to 2 weeks until chylothorax
ceases and chest tubes are removed. Milder cases
are treated with MCT oil based formulas from the
beginning with or without octreotide infusion.
Cases not responding to conservative manage-
ment after 3–4 weeks are discussed for thoracic
duct ligation. All cases with documented chylo-
thorax are screened by Doppler ultrasound to rule
out the possibility of venous thrombosis in the
neck veins and superior vena cava (SVC) as a pos-
sible cause of chylothorax (Figure 1).Statistics
GraphPad statistical program was used to ana-
lyze data. Student t-test was applied to compare
means of continuous variable between control
and patients chylothorax groups. Chi-square test
was used to compare means of categorical values
in the control and chylothorax groups.Results
The total number of patients who underwent
cardiac surgery during the study period was 1135;
of these, 57 cases (5%) were complicated with chy-
lothorax in the postoperative period; 20 (35%) were
redo surgical cases; 30 patients (54%) were males,
while 27 (47%) were females; and ages ranged from
4 to 2759 days. There were no differences between
the chylothorax group and the control group in
relation to any of the demographic data including
age, gender, weight, height or the risk category
(Table 1). The most common surgeries complicated
with chylothorax were the single ventricle repair
surgeries (Glenn–Fontan):15 cases (27%), followed
by arch repair surgeries: 10 cases (18%); ventricular
septal defect surgeries: 10 cases (18%); atrioven-
tricular septal defect surgeries: 7 cases (12%); arte-
rial switch surgeries: 6 cases (11%), and others: 8
cases (14%). The ICU stay and the length of hospi-
tal stay were significantly longer in the chylothorax
group, as were some of the early postoperative
parameters such as incidences of sepsis, ventila-
tion time, and inotropes duration. There was also
a strong tendency in the chylothorax group toward
a longer ventilation time (P = 0.059) and a higher
re-intubation rate (P = 0.06), but these were not
statistically significant (Tables 2 and 3). When we
compared the early postoperative complications,
we found that the incidence of septicemia was sig-
nificantly higher in the chylothorax group as com-
pared to the control group (P = 0.008). All cases
responded to conservative management except
one case which required surgical thoracic duct
ligation (1/57, 1.7%). There was no significant dif-
ference in mortality between the chylothorax and
the control group.
Table 2. Comparison of the early post operative data.
Variable Chylothorax (57) Control (53) P value
ICU stay (days) 12 ± 18 5.8 ± 9 0.0259
LOHS (days) 37 ± 40 10.4 ± 14 0.0001
Bypass time (min) 106 ± 82 112 ± 53 0.65
Ventilation time (h) 141 ± 384 40 ± 42 0.059
Inotropes duration (h) 107 ± 196 52 ± 43 0.048
No. of inotropes >2 18/57 14/53 0.6750
ICU: intensive care unit, LOHS: Length of hospital stay, h: hours, min: Minutes, no: number.
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Table 3. Comparison of early postoperative complications.
Variable Chylothorax (57) Control (53)) P value
Mortality 3/57 1/53 0.6191
Re-intubations 7/57 1/53 0.0618
CPR 1/57 1/53 1.000
Delayed sterna closure 2/57 1/53 1.000
Septicemia 12/57 2/53 0.0086
Arrhythmias 6/57 11/53 0.1880
Acute renal failure 3/57 1/57 0.6191
Pneumothorax 11/57 7/53 0.4466
CPR: cardio-pulmonary resuscitation.
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Chylothorax in children is not a rare complica-
tion after pediatric cardiac surgery, and it is a
potentially life threatening complication. The
mechanisms of postoperative chylothorax were
mostly due to direct trauma to the lymphatic
vessels or the thoracic duct and less commonly
to secondary to central venous hypertension after
cavo-pulmonary connection (Glenn or Fontan), or
venous thrombosis [6].
In the present study, we noticed the increased
incidence of chylothorax in redo cases (35%), sin-
gle repair cases (27%), aortic arch repairs (18%),
ventricular septal defect (VSD) and atrio ventricu-
lar septal defect (AVSD) repairs (18%) and (12%),
respectively. These numbers were comparable to
the numbers reported by Chan et al., except for
the increased incidence in Tetralogy of Fallot pa-
tients in the Chan study, reaching 18% compared
to our incidence of 3.5% [8]. Incidences of chylo-
thorax in our study population (5%) are similar
to recently reported studies from other centers
with incidences of 4.7% as reported by Cormack
et al., [7] 3.8% by Chan et al., [8] and 6% by Serar
et al. [9]. This is higher than older studies reporting
1% from 1979 to 87 by Allen et al. [10] and 1.1%
from 1961 to 1969 by Higgins et al. [11]. This change
is likely due to increased complexity of the
patients, the increased number of single ventricle
repair and the increase in the number of redo
surgeries. The mortality of patients complicatedwith chylothorax in the present study was 5%
and this is similar to previous reports which ran-
ged from 6% to 21% [12,13,7].
This study reports an impact of chylothorax on
postoperative morbidity in the form of a signifi-
cant increase in ICU stay, length of hospital stay,
and on some early postoperative parameters like
the significant increase in the incidence of sepsis,
ventilation time, and inotropes duration. There
was also a strong tendency in the chylothorax
group toward a longer ventilation time (P = 0.059)
and a higher re-intubation rate (P = 0.06) but it
was not statistically significant (Tables 2 and 3).
The increased incidence of sepsis can be ex-
plained by the increased ICU stay and the need
for TPN which requires insertion of a central ve-
nous access for long duration, continuous chest
tube drainage, and nutritional loss. Immunosup-
pression increases risk for sepsis, and therefore
regular bacteriological screening is useful in the
early treatment of opportunistic infections. The
risk of fulminant or fungal infections is well
known [14,15]. Unfortunately, there is little data
to guide treatment of postoperative chylothorax,
leading to wide practice variation. Most published
pediatric studies are limited to small case series
and case reports [13]. All our study cases re-
sponded to medical management including chest
tube drainage, TPN, octreotide, and MCT oil-
based formulas, except one case requiring thoracic
duct ligation (1/57, 1.7%). The optimal manage-
ment of a chylothorax is unclear because no
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OPERATIVE OUTCOME AFTER PEDIATRIC
CARDIOVASCULAR SURGERYprospective studies exist to guide therapy; and dif-
ferent protocols and strategies are applied in dif-
ferent centers. Chest tube placement is typically
performed in patients with a postsurgical chylo-
thorax or in those with chylothoraces that rapidly
re-accumulate [16]. Fasting with TPN or a reduced
fat diet decreases the flow of chyle through the
thoracic duct and allows spontaneous closure of
a thoracic duct leak. Dietary exclusion of long-
chain triglycerides avoids their conversion into
monoglycerides and free fatty acids, which are
transported as chylomicrons to the intestinal
lymph ducts. A reduced fat diet may be supple-
mented with medium chain triglycerides (MCTs),
which are absorbed directly into intestinal cells
and transported directly to the liver via the portal
vein, thus bypassing the thoracic duct. MCTs are
commercially available as MCT oil [17]. In resis-
tant cases, surgery is indicated and in our series
one case required thoracic duct ligation, and the
patient survived. Most authors agree that surgery
should be reserved for failure of medical treat-
ment [19,20]. To date, there has been no agree-
ment on how long to wait for the success of the
medical treatment. Some authors recommend sur-
gery within 5–7 days to limit the morbidity and
mortality associated with the operation [21,22,5].
Others recommend waiting longer, about 2 weeks
or even more to give medical treatment a suffi-
cient chance [8,24,25]. Two surgical strategies pre-
dominate: direct wound ligature or en masse
supradiaphragmatic ligature. For non-traumatic
causes, other methods have been developed
which are indicated in very rare cases: pleuroper-
itoneal shunt, pleurectomy, pleurodesis, or even
radiotherapy [18]. There are other modalities in
treatment such as pleurodesis, pleurectomy, bio-
logic glue, pleuroperitoneal shunts, and others
[13,26]. Pleurodesis has been recommended for
refractory chylothorax that did not respond to
medical or surgical intervention [26]. Some
authors recommend fenestrating the diaphragm
or creating pleura-peritoneal windows [26]. None
of our patients required these procedures and
the vast majority responded to conservative man-
agement or thoracic duct ligation with no need for
further interventions recommended for severe
refractory cases. Our study has limitations as a
retrospective study, with a small number of pa-
tients, possibility of bias during selection of the
control group, and lack of hemodynamic data of
both groups especially those with single ventricle
repair. We recommend further studies avoiding
these limitations.References
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